These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Management of blinding disease: loss of immunity and superinfection. Evans BG Eye (Lond); 2005 Oct; 19(10):1035-6. PubMed ID: 16304581 [TBL] [Abstract][Full Text] [Related]
5. Opportunistic infections in patients with HIV and AIDS. Fungal and parasitic infections. Martinez J; Temesgen Z J Med Liban; 2006; 54(2):84-90. PubMed ID: 17086999 [TBL] [Abstract][Full Text] [Related]
6. Coinfection and superinfection in patients with long-term, nonprogressive HIV-1 disease. Casado C; Pernas M; Alvaro T; Sandonis V; García S; Rodríguez C; del Romero J; Grau E; Ruiz L; Lopez-Galindez C J Infect Dis; 2007 Sep; 196(6):895-9. PubMed ID: 17703421 [TBL] [Abstract][Full Text] [Related]
7. Opportunistic infection of HIV-infected/AIDS patients in Indonesia: problems and challenge. Pohan HT Acta Med Indones; 2006; 38(3):169-73. PubMed ID: 17175600 [TBL] [Abstract][Full Text] [Related]
8. Current trends of HIV disease of the mouth. Frezzini C; Leao JC; Porter S J Oral Pathol Med; 2005 Oct; 34(9):513-31. PubMed ID: 16138890 [TBL] [Abstract][Full Text] [Related]
9. Tuberculosis-HIV co-infection: policy and epidemiology in 25 countries in the WHO European region. Lazarus JV; Olsen M; Ditiu L; Matic S HIV Med; 2008 Jul; 9(6):406-14. PubMed ID: 18410353 [TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology of HIV-1 variants in the global AIDS pandemic: an update. Thomson MM; Nájera R AIDS Rev; 2005; 7(4):210-24. PubMed ID: 16425961 [TBL] [Abstract][Full Text] [Related]
13. HIV/AIDS 2007: an end-of-year commentary. De Cock KM Int J Tuberc Lung Dis; 2007 Dec; 11(12):1267-9. PubMed ID: 18034945 [No Abstract] [Full Text] [Related]
14. [Tuberculosis in Poland, Europe, and world. Part II--mortality, drug resistance and HIV infection]. Zielonka TM Pol Merkur Lekarski; 2006 Sep; 21(123):253-61. PubMed ID: 17163187 [TBL] [Abstract][Full Text] [Related]
15. HIV-1 superinfection is not a common event. Diaz RS; Pardini R; Catroxo M; Operskalski EA; Mosley JW; Busch MP J Clin Virol; 2005 Aug; 33(4):328-30. PubMed ID: 16036183 [TBL] [Abstract][Full Text] [Related]
16. Drug induced superinfection in HIV and the evolution of drug resistance. Leontiev VV; Maury WJ; Hadany L Infect Genet Evol; 2008 Jan; 8(1):40-50. PubMed ID: 18024234 [TBL] [Abstract][Full Text] [Related]
17. Viral opportunistic infections in HIV-infected adults. Tsigrelis C; Berbari E; Temesgen Z J Med Liban; 2006; 54(2):91-6. PubMed ID: 17087000 [TBL] [Abstract][Full Text] [Related]
18. The burden of HIV-associated cryptococcal disease. Harrison TS AIDS; 2009 Feb; 23(4):531-2. PubMed ID: 19240459 [No Abstract] [Full Text] [Related]
19. Recovery of viremic control after superinfection with pathogenic HIV type 1 in a long-term elite controller of HIV type 1 infection. Rachinger A; Navis M; van Assen S; Groeneveld PH; Schuitemaker H Clin Infect Dis; 2008 Dec; 47(11):e86-9. PubMed ID: 18947331 [TBL] [Abstract][Full Text] [Related]
20. Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. Smith DM; Strain MC; Frost SD; Pillai SK; Wong JK; Wrin T; Liu Y; Petropolous CJ; Daar ES; Little SJ; Richman DD Virology; 2006 Nov; 355(1):1-5. PubMed ID: 16962152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]